Loading...
OTCM
FBDS
, Last price  
USD
Name

Fuss Brands Corp

Chart & performance

D1W1MN
OTCM:FBDS chart
P/E
—
P/B
—
EPS
—
Vol. 1Y
—
Shs. 5Y
67.47%
Rev. 5Y
%
Div Yld LY
—
Div Yld TTM
—
Revenues
0
4,689,00010,991,00026,274,00059,064,00063,060,00050,289,0000028,040,00036,164,00043,412,00055,184,00072,714,00072,714,000000000
Net income
-3m
L+445.54%
-1,796,000-6,574,000-443,000902,392-1,123,000-3,453,000878,7118779,597,00011,981,00014,847,00017,869,00025,919,000-110,00000-325,000-107,000-505,000-2,755,000
CFO
-423k
L+325.00%
-4,645-702,248-894,143-184,983-3,962,8503,744,043-3,374,672-1,316,8408,876,363-1,227,94113,067,53323,835,56221,139,70721,139,707-109,896,1640-75,088-106,366-99,615-423,366
Dividend
Mar 16, 20060.0014 USD/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Fuss Brands Corp. does not have significant operations. It intends to explore and identify business opportunities within the United States, including a potential acquisition of an operating entity through a reverse merger, asset purchase, or similar transaction. The company was formerly known as China Botanic Pharmaceutical Inc. and changed its name to Fuss Brands Corp. in July 2022. Fuss Brands Corp. was incorporated in 1988 and is based in New York, New York.

Key people

Shaoming Li
Chairman of the Board, President, Chief Executive Officer · since 2006
Weiqiu Dong
Chief Financial Officer · since 2010
Jiang He
Secretary · since 2006
Dianjun Pi
Director · since 2010
Changxiong Sun
Independent Director · since 2010
Bingchun Wu
Independent Director · since 2010
Jack Zhao
Independent Director · since 2013
IPO date
Jun 07, 2013
Employees
1
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFY
2024‑102023‑102022‑102021‑102020‑10
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT